Top Story

Novel apolipoprotein A-I formulation studied in AEGIS-I

November 22, 2014

A new phase 2b trial will assess a novel apolipoprotein A-I formulation and its effect on markers of reverse cholesterol transport and the stabilization of atherosclerotic lesions, according to a press release.

The randomized, placebo-controlled, dose-ranging AEGIS-I study is designed to evaluate the safety and tolerability of multiple weekly infusions of CSL112 (CSL Limited) in a cohort of 1,200 patients with acute MI.

In the Journals

EPA with statins may reduce periprocedural MI in PCI

November 21, 2014
Patients receiving eicosapentaenoic acid with statins before PCI experienced reduced type IVa MI compared with those receiving statins only, recent findings…
In the Journals

CDC: Overall heart disease death rate fell, increased in certain subtypes

November 21, 2014
In a letter published in JAMA, researchers from the CDC reported that mortality rates for heart disease overall have declined, but increases were seen in certain…
thumbnail for video 3903437995001 Meeting News CoverageVideo

VIDEO: Satellite-based ECG system may improve outcomes for patients with STEMI

November 21, 2014
CHICAGO — Srihari S. Naidu, MD, director of the cardiac catheterization lab at Winthrow University Hospital in Mineola, New York, provides perspective on results…
Meeting News CoveragePerspective

CONTROL-HTN: Mechanical device improved BP in patients with resistant arterial hypertension

November 21, 2014
Patients with treatment-resistant arterial hypertension had significant reductions in office-measured and ambulatory BP following arteriovenous anastomosis with a…
More News Headlines »
Experts Take: Dialogue on HTG

Experts’ Take: Dialogue on Hypertriglyceridemia

This activity is supported by an independent educational grant from Amarin Pharma Inc.

Lead by genetic studies, recent data describe a causal role of triglycerides (TG) in the formation of atherosclerosis…
More »
Meeting News Coverage Video
Healio AHA2014 Zile th

New data may yield a 'change in the paradigm' of HF therapy

November 18, 2014
CHICAGO — Further analyses of the PARADIGM-HF trial provide more information on the efficacy of an…
More »
Controversial Issues and Challenging Cases

Controversial Issues and Challenging Cases in the New Frontier of Obesity Online Activity

This activity is supported by an educational grant from Eisai Inc.

Obesity has become a world-wide issue of utmost importance as its incidence and prevalence are associated with dramatic…
More »